Abbott Laboratories (ABT)
Operating profit margin
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 7,787,000 | 7,548,000 | 7,182,000 | 6,879,000 | 6,753,000 | 6,613,000 | 6,438,000 | 6,453,000 | 6,030,000 | 6,055,000 | 6,877,000 | 8,362,000 | 9,368,000 | 10,287,000 | 9,952,000 | 9,200,000 | 9,167,000 | 8,001,000 | 6,645,000 | 5,291,000 |
| Revenue (ttm) | US$ in thousands | 43,843,000 | 43,109,000 | 42,344,000 | 41,950,000 | 41,217,000 | 40,725,000 | 40,326,000 | 40,109,000 | 39,959,000 | 40,226,000 | 41,505,000 | 43,653,000 | 45,030,000 | 45,548,000 | 44,514,000 | 43,075,000 | 42,308,000 | 40,233,000 | 37,338,000 | 34,608,000 |
| Operating profit margin | 17.76% | 17.51% | 16.96% | 16.40% | 16.38% | 16.24% | 15.96% | 16.09% | 15.09% | 15.05% | 16.57% | 19.16% | 20.80% | 22.58% | 22.36% | 21.36% | 21.67% | 19.89% | 17.80% | 15.29% |
September 30, 2025 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $7,787,000K ÷ $43,843,000K
= 17.76%
Peer comparison
Sep 30, 2025
Company name
Symbol
Operating profit margin
Abbott Laboratories
ABT
17.76%
CONMED Corporation
CNMD
8.79%
Stryker Corporation
SYK
22.44%
See also:
Abbott Laboratories Operating Profit Margin (Quarterly Data)